Strides Pharma Science Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Assets

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Cash & Equivalents	-	1,887	1,126	1,610	3,035	1,707
Short-Term Investments	-	157.86	165.59	227.8	63.63	134.55
Trading Asset Securities	-	-	695	1,058	508.4	-
Cash & Short-Term Investments	2,045	2,045	1,986	2,896	3,607	1,842
Cash Growth	2.95%	2.95%	-31.41%	-19.72%	95.84%	-32.99%
Accounts Receivable	-	12,890	12,029	11,419	12,994	12,073
Other Receivables	-	2,459	2,040	1,462	936.49	5,899
Receivables	-	15,430	14,174	13,008	14,008	18,020
Inventory	-	16,348	12,776	11,262	11,465	11,738
Prepaid Expenses	-	747.55	617.23	706.94	639.29	541.85
Other Current Assets	-	1,563	1,436	1,817	2,714	1,476
Total Current Assets	-	36,133	30,989	29,690	32,434	33,618
Property, Plant & Equipment	-	11,536	9,803	9,585	13,726	15,136
Long-Term Investments	-	3,005	3,437	2,015	4,422	5,416
Goodwill	-	5,944	5,466	5,294	5,138	4,859
Other Intangible Assets	-	7,997	5,680	5,271	5,631	6,250
Long-Term Deferred Tax Assets	-	2,839	2,691	2,673	2,650	2,151
Other Long-Term Assets	-	1,819	2,422	3,368	2,385	2,297
Total Assets	-	69,272	60,487	58,398	66,384	69,759

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Accounts Payable	-	13,097	10,325	8,516	9,823	10,715
Accrued Expenses	-	1,509	1,542	1,229	1,287	1,348
Short-Term Debt	-	10,393	11,364	15,742	13,308	14,965
Current Portion of Long-Term Debt	-	770.36	880.06	1,689	3,039	4,598
Current Portion of Leases	-	374.53	325.62	307.05	514.39	465.98
Current Income Taxes Payable	-	483.95	340.37	404.16	267.11	238.11
Other Current Liabilities	-	2,327	1,139	905.91	1,664	1,786
Total Current Liabilities	-	28,955	25,915	28,793	29,902	34,117
Long-Term Debt	-	5,523	5,712	6,715	11,398	8,356
Long-Term Leases	-	518.4	514.58	716.35	2,037	1,865
Pension & Post-Retirement Benefits	-	643.29	602.69	548.33	408.38	450.44
Long-Term Deferred Tax Liabilities	-	1,207	1,194	403.45	445.71	357.19
Other Long-Term Liabilities	-	932.48	684.16	504.78	464.61	780.18
Total Liabilities	-	37,779	34,623	37,680	44,655	45,925

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Common Stock	-	921.73	921.63	919	903.03	897.9
Additional Paid-In Capital	-	15,101	15,094	18,233	17,545	17,322
Retained Earnings	-	13,824	8,631	1,197	2,037	4,060
Comprehensive Income & Other	-	1,229	871.3	906.9	1,638	1,312
Total Common Equity	31,076	31,076	25,518	21,256	22,123	23,592
Minority Interest	-	417.72	346.33	-538.57	-393.75	240.88
Shareholders' Equity	31,493	31,493	25,865	20,717	21,729	23,833
Total Liabilities & Equity	-	69,272	60,487	58,398	66,384	69,759

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Total Debt	17,580	17,580	18,796	25,169	30,296	30,250
Net Cash (Debt)	-15,535	-15,535	-16,810	-22,273	-26,689	-28,408
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-168.52	-168.54	-182.68	-244.75	-296.27	-316.54
Filing Date Shares Outstanding	92.19	92.17	92.16	91.9	90.3	89.8
Total Common Shares Outstanding	92.19	92.17	92.16	91.9	90.3	89.79
Working Capital	-	7,178	5,074	897.42	2,532	-498.44
Book Value Per Share	337.15	337.15	276.88	231.29	244.98	262.75
Tangible Book Value	17,135	17,135	14,373	10,690	11,354	12,483
Tangible Book Value Per Share	185.90	185.90	155.95	116.33	125.73	139.03
Land	-	1,476	1,429	1,416	1,410	1,383
Buildings	-	3,856	3,413	3,225	3,844	4,205
Machinery	-	10,872	9,475	9,048	12,539	13,042
Construction In Progress	-	1,611	996.46	798.79	482.59	562.29